Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Zhengzhou UniversityNo recent work listed

Yun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3803-7014; OpenAlex author ID A5100377674. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 trial · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 2

  1. Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer. Co-author DOI 10.14309/ctg.0000000000000487↗
  2. Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. First author DOI 10.1186/s12935-021-02390-0↗

Trials 1

  1. Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions Principal investigator NCT02789371↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bin Cheng · 2 shared papers, 1 shared trial, 2016–2022 · strength 0.47
  2. Zhou Luan · 2 shared papers, 2021–2022 · strength 0.28
  3. Yuchong Zhao · 2 shared papers, 2021–2022 · strength 0.28
  4. Ronghua Wang · 1 shared paper, 2022 · strength 0.15
  5. Jinlin Wang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.